Financial results - VIVICARDIOMED S.R.L.

Financial Summary - Vivicardiomed S.r.l.
Unique identification code: 40193091
Registration number: J40/16769/2018
Nace: 8622
Sales - Ron
55.165
Net Profit - Ron
42.142
Employees
1
Open Account
Company Vivicardiomed S.r.l. with Fiscal Code 40193091 recorded a turnover of 2024 of 55.165, with a net profit of 42.142 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Vivicardiomed S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 23.630 18.311 21.774 29.483 40.785 55.165
Total Income - EUR - - - - 23.634 18.311 21.774 29.483 40.785 55.165
Total Expenses - EUR - - - - 1.190 1.303 2.277 2.838 9.683 11.450
Gross Profit/Loss - EUR - - - - 22.444 17.008 19.497 26.645 31.102 43.714
Net Profit/Loss - EUR - - - - 21.735 16.485 18.946 25.973 30.756 42.142
Employees - - - - 0 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 36.0%, from 40.785 euro in the year 2023, to 55.165 euro in 2024. The Net Profit increased by 11.559 euro, from 30.756 euro in 2023, to 42.142 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Vivicardiomed S.r.l.

Rating financiar

Financial Rating -
VIVICARDIOMED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Vivicardiomed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Vivicardiomed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Vivicardiomed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Vivicardiomed S.r.l. - CUI 40193091

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 0 0 0 488 143 0
Current Assets - - - - 23.245 9.311 22.539 11.452 42.656 43.572
Inventories - - - - 72 70 0 0 0 0
Receivables - - - - 42 41 0 0 0 28.188
Cash - - - - 23.131 9.199 22.539 11.452 42.656 15.384
Shareholders Funds - - - - 21.551 16.305 18.986 7.808 38.540 42.191
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 1.694 -6.994 3.553 4.132 4.259 1.381
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 43.572 euro in 2024 which includes Inventories of 0 euro, Receivables of 28.188 euro and cash availability of 15.384 euro.
The company's Equity was valued at 42.191 euro, while total Liabilities amounted to 1.381 euro. Equity increased by 3.866 euro, from 38.540 euro in 2023, to 42.191 in 2024.

Risk Reports Prices

Reviews - Vivicardiomed S.r.l.

Comments - Vivicardiomed S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.